[{"AccountsPayableCurrent_0_Q3_USD":3683000.0,"OperatingIncomeLoss_3_Q3_USD":-55083000.0,"OperatingIncomeLoss_1_Q3_USD":-24576000.0,"OperatingExpenses_3_Q3_USD":55083000.0,"OperatingExpenses_1_Q3_USD":24576000.0,"NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_3_Q3_USD":129000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":-55025000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":-24566000.0,"NetIncomeLoss_3_Q3_USD":-55025000.0,"NetIncomeLoss_1_Q3_USD":-24566000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-50613000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-405000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":1948000.0,"LiabilitiesCurrent_0_Q3_USD":12488000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":399728000.0,"Liabilities_0_Q3_USD":14556000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":184000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":102000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_0_Q3_USD":519000.0,"LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_0_Q3_USD":482000.0,"LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_0_Q3_USD":433000.0,"LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_0_Q3_USD":446000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":2283000.0,"LeaseCost_3_Q3_USD":557000.0,"LeaseCost_1_Q3_USD":269000.0,"InterestPaidNet_3_Q3_USD":7000.0,"InterestIncomeExpenseNonoperatingNet_3_Q3_USD":-10000.0,"InterestIncomeExpenseNonoperatingNet_1_Q3_USD":-4000.0,"OperatingLeaseCost_1_Q3_USD":132000.0,"OperatingLeaseCost_3_Q3_USD":229000.0,"OperatingLeaseLiability_0_Q3_USD":2099000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":416000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":40234159.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":40396188.0,"StockIssuedDuringPeriodValueShareBasedCompensation_3_Q3_USD":2021000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q3_USD":533000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_3_Q3_USD":103000.0,"StockholdersEquity_0_Q3_USD":385172000.0,"ShareBasedCompensation_3_Q3_USD":8228000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":1812000.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_3_Q3_USD":834000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-173547000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":39276000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":18214000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":562000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":2042000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":601000.0,"ProceedsFromStockPlans_3_Q3_USD":103000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":2022000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":3814000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":405000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":68000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":14000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":2068000.0,"OtherAssetsNoncurrent_0_Q3_USD":10203000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":102000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.035,"OperatingLeaseRightOfUseAsset_0_Q3_USD":1900000.0,"OperatingLeasePayments_3_Q3_USD":141000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":1683000.0,"ProfitLoss_3_Q3_USD":-55025000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_3_Q3_USD":2063000.0,"IncreaseDecreaseInOtherAccruedLiabilities_3_Q3_USD":2333000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":3620000.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q3_USD":0.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q3_USD":0.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q3_USD":0.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":2173000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.37,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.61,"DepreciationDepletionAndAmortization_3_Q3_USD":17000.0,"CommonStockValue_0_Q3_USD":40000.0,"CommonStockSharesOutstanding_0_Q3_shares":40486287.0,"CommonStockSharesIssued_0_Q3_shares":40486287.0,"CommonStockSharesAuthorized_0_Q3_shares":1000000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":9443214.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q3_USD":0.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":385149000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":385149000.0,"AssetsCurrent_0_Q3_USD":388963000.0,"Assets_0_Q3_USD":399728000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":4909185.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":8228000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":4191000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":8228000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":4191000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":558679000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":39000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":279000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q3_USD":7210000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_Q3_USD":-49070000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":40396188.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_1_Q3_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_1_Q3_USD":0.0,"IncomeTaxesPaid_3_Q3_USD":274000.0,"IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_3_Q3_USD":-1.37,"IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_1_Q3_USD":-0.61,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-55025000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-24566000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":15807000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":6362000.0,"FinanceLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.017,"FinanceLeaseRightOfUseAssetAmortization_3_Q3_USD":257000.0,"FinanceLeaseRightOfUseAssetAmortization_1_Q3_USD":112000.0,"FinanceLeaseRightOfUseAsset_0_Q3_USD":900000.0,"FinanceLeasePrincipalPayments_3_Q3_USD":177000.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":14000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_3_Q3_USD":0.0,"FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":108000.0,"FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths_0_Q3_USD":432000.0,"FinanceLeaseLiabilityPaymentsDue_0_Q3_USD":828000.0,"FinanceLeaseLiabilityNoncurrent_0_Q3_USD":385000.0,"FinanceLeaseLiabilityCurrent_0_Q3_USD":429000.0,"FinanceLeaseLiability_0_Q3_USD":814000.0,"FinanceLeaseInterestPaymentOnLiability_3_Q3_USD":7000.0,"FinanceLeaseInterestExpense_3_Q3_USD":10000.0,"FinanceLeaseInterestExpense_1_Q3_USD":3000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_3_Q3_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_1_Q3_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_3_Q3_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_1_Q3_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_3_Q3_USD":0.0,"FinanceLeaseLiabilityPaymentsDueInRollingYearTwo_0_Q3_USD":288000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":40234159.0,"Ticker":"ALXO","CIK":"1810182","name":"ALX ONCOLOGY HOLDINGS INC","OfficialName":"ALX Oncology Holdings Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"632216571.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211112"}]